<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04662190</url>
  </required_header>
  <id_info>
    <org_study_id>CEI 20-16</org_study_id>
    <nct_id>NCT04662190</nct_id>
  </id_info>
  <brief_title>Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.</brief_title>
  <official_title>Eficàcia i Seguretat de la descompressió orbitària en Orbitopatia distiroïdal Utilitzant Models Individualitzats d'impressió 3D Per la planificació i simulació de la Cirurgia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Althaia Xarxa Assistencial Universitària de Manresa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Societat Catalana d'Oftalmologia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Althaia Xarxa Assistencial Universitària de Manresa</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicentric, randomized, single-blinded clinical trial to evaluate the efficacy&#xD;
      and safety of 3D printing for the planification and simulation of orbital decompression&#xD;
      surgery for thyroid-associated orbitopathy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 4, 2021</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative complications</measure>
    <time_frame>6 months</time_frame>
    <description>Intraoperative complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>6 months</time_frame>
    <description>Postoperative complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exophthalmos</measure>
    <time_frame>6 months</time_frame>
    <description>Exophthalmos measured in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diplopia</measure>
    <time_frame>6 months</time_frame>
    <description>Diplopia correction</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Thyroid Associated Ophthalmopathy</condition>
  <condition>Surgical Procedure, Unspecified</condition>
  <arm_group>
    <arm_group_label>Control grup</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgery planned, simulated and guided by 3D printing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D printing model/guide.</intervention_name>
    <description>Orbital decompression surgery will be previously planned and simulated using 3D-printed individualized models. In the operating room, surgery will be assisted with 3D-printed individualized guides.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard surgery</intervention_name>
    <description>Orbital decompression surgery will be previously planned and simulated using the actual standard methods.</description>
    <arm_group_label>Control grup</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of inactive thyroid-associated orbitopathy requiring bilateral orbital&#xD;
             decompression (moderate-severe in EUGOGO classification).&#xD;
&#xD;
          -  Volunteers older than 18 years old.&#xD;
&#xD;
          -  Ability to read.&#xD;
&#xD;
          -  Acceptation to participate and signature of informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Younger than 18 years old.&#xD;
&#xD;
          -  Previous orbital surgery.&#xD;
&#xD;
          -  Any coexisting disease preventing follow-up.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eduard Pedemonte-Sarrias, Md, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Althaia Xarxa Assistencial Universitària de Manresa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eduard Pedemonte-Sarrias, MD, PhD</last_name>
    <phone>+34678091233</phone>
    <email>epedemonte@althaia.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Arnau, PhD</last_name>
    <email>aarnau@althaia.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Eduard Pedemonte Sarrias</name>
      <address>
        <city>Manresa</city>
        <state>Barcelona</state>
        <zip>08243</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Arnau Bartés, PhD</last_name>
      <phone>+34 93 875 93 00</phone>
      <phone_ext>3414</phone_ext>
      <email>aarnau@althaia.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 6, 2020</study_first_submitted>
  <study_first_submitted_qc>December 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2020</study_first_posted>
  <last_update_submitted>July 25, 2021</last_update_submitted>
  <last_update_submitted_qc>July 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Althaia Xarxa Assistencial Universitària de Manresa</investigator_affiliation>
    <investigator_full_name>Eduard Pedemonte-Sarrias</investigator_full_name>
    <investigator_title>Ophthalmologist, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Diseases</mesh_term>
    <mesh_term>Graves Ophthalmopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

